Head-to-Head Comparison of Sedation and Somnolence Among 37 Antipsychotics in Schizophrenia, Bipolar Disorder, Major Depression, Autism Spectrum Disorders, Delirium, and Repurposed in COVID-19, Infectious Diseases, and Oncology From the FAERS, 2004–2020

Head-to-Head Comparison of Sedation and Somnolence Among 37 Antipsychotics in Schizophrenia, Bipolar Disorder, Major Depression, Autism Spectrum Disorders, Delirium, and Repurposed in COVID-19, Infectious Diseases, and Oncology From the FAERS, 2004–2020

Objective: Antipsychotic compounds are known to induce sedation somnolence and have expanded clinical indications beyond schizophrenia to regulatory approval in bipolar disorder, treatment-resistant depression, and is being repurposed in infectious diseases and oncology. However, the medical science...

Full description

Bibliographic Details
Main Authors: Andy R. Eugene, Beata Eugene, Marek Masiak, Jolanta Sylwia Masiak
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Pharmacology
Subjects:
sedation
sleep
pharmacogenomics
treatment resistant
major tranquilizers
COVID-19
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.621691/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.621691/full

Similar Items